Intervention Review

You have free access to this content

Interferon alpha for the adjuvant treatment of cutaneous melanoma

  1. Simone Mocellin1,2,*,
  2. Marko B Lens3,
  3. Sandro Pasquali4,
  4. Pierluigi Pilati4,
  5. Vanna Chiarion Sileni5

Editorial Group: Cochrane Skin Group

Published Online: 18 JUN 2013

Assessed as up-to-date: 22 AUG 2012

DOI: 10.1002/14651858.CD008955.pub2


How to Cite

Mocellin S, Lens MB, Pasquali S, Pilati P, Chiarion Sileni V. Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD008955. DOI: 10.1002/14651858.CD008955.pub2.

Author Information

  1. 1

    IOV-IRCCS, Istituto Oncologico Veneto, Padova, Italy

  2. 2

    University of Padova, Dept. Surgery Oncology and Gastroenterology, Padova, Veneto, Italy

  3. 3

    King's College london, Genetic Epidemiology Unit, London, UK

  4. 4

    University of Padova, Meta-Analysis Unit, Department of Surgery, Oncology and Gastroenterology, Padova, Italy

  5. 5

    Veneto Region Oncology Research Institute, Medical Oncology Unit 2, Padova, Italy

*Simone Mocellin, Dept. Surgery Oncology and Gastroenterology, University of Padova, Via Giustiniani 2, Padova, Veneto, 35128, Italy. simone.mocellin@unipd.it. mocellins@hotmail.com.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 18 JUN 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vernon K Sondak, Grant A McArthur, Adjuvant immunotherapy for cancer: the next step, The Lancet Oncology, 2015, 16, 5, 478

    CrossRef

  2. 2
    Michael A Henderson, Bryan H Burmeister, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers, Brendon J Coventry, Scott Babington, Joao Duprat, Harald J Hoekstra, John F Thompson, Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial, The Lancet Oncology, 2015, 16, 9, 1049

    CrossRef

  3. 3
    N. Mozzillo, S. Pasquali, M. Santinami, A. Testori, M. Di Marzo, A. Crispo, R. Patuzzo, F. Verrecchia, G. Botti, M. Montella, C.R. Rossi, C. Caracò, Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study, European Journal of Surgical Oncology (EJSO), 2015, 41, 7, 823

    CrossRef

  4. 4
    Sandro Pasquali, Andrew Spillane, Contemporary controversies and perspectives in the staging and treatment of patients with lymph node metastasis from melanoma, especially with regards positive sentinel lymph node biopsy, Cancer Treatment Reviews, 2014, 40, 8, 893

    CrossRef

  5. 5
    Vernon K. Sondak, Geoffrey T. Gibney, Indications and Options for Systemic Therapy in Melanoma, Surgical Clinics of North America, 2014, 94, 5, 1049

    CrossRef

  6. 6
    Vernon K Sondak, Geoffrey T Gibney, Setting the bar for adjuvant treatment of melanoma, The Lancet Oncology, 2014, 15, 6, 547

    CrossRef

  7. 7
    Vernon K. Sondak, Geoffrey T. Gibney, Surgical Management of Melanoma, Hematology/Oncology Clinics of North America, 2014, 28, 3, 455

    CrossRef

  8. 8
    Vernon K. Sondak, Jane L. Messina, Unusual Presentations of Melanoma, Surgical Clinics of North America, 2014, 94, 5, 1059

    CrossRef

  9. 9
    Eshini Perera, Neiraja Gnaneswaran, Ross Jennens, Rodney Sinclair, Malignant Melanoma, Healthcare, 2013, 2, 1, 1

    CrossRef

  10. 10
    Yao Cheng, Xianze Xiong, Jiong Lu, Sijia Wu, Rongxing Zhou, Yixin Lin, Nansheng Cheng, Early versus delayed appendicectomy for appendiceal phlegmon or abscess, The Cochrane Library,
  11. 11
    Sandro Pasquali, Richard Kefford, Vanna Chiarion Sileni, Donato Nitti, Carlo Riccardo Rossi, Pierluigi Pilati, Simone Mocellin, Systemic treatments for metastatic cutaneous melanoma, The Cochrane Library,
  12. 12
    Jane Burch, What are the benefits and harms of the adjuvant treatment interferon alpha in people with cutaneous melanoma?, Cochrane Clinical Answers,
  13. 13
    Jane Burch, Pablo Fernandez-Peñas, What are the benefits and harms of the adjuvant treatment interferon alpha in people with stage II or III cutaneous melanoma?, Cochrane Clinical Answers,